The Role of Nontraditional Glycemic Markers in Diabetes and Albuminuria

描述（由申请人提供）：糖尿病是一种与微血管并发症风险增加相关的慢性疾病。在美国，13%的成年人患有糖尿病，另外30%的成年人处于患糖尿病的高风险中。非传统的血糖标志物糖化白蛋白（GA），果糖胺，和1，5-脱水葡萄糖醇（1，5-AG））可以提供额外的预后信息，以确定个人在发展糖尿病和微血管并发症的高风险。GA、果糖胺和1，5-AG反映了短期高血糖症，并已显示出生理效应，包括启动信号通路，其在糖尿病微血管并发症的发展中具有活性。此外，GA，果糖胺和1，5-AG水平的重要种族差异已被报道，在患有和不患有糖尿病的个体中，非洲裔美国人具有比白人更高的GA和果糖胺以及更低的1，5-AG水平。本研究项目的目的是：1）评价GA、果糖胺和1，5-AG与糖尿病发病的相关性; 2）评价GA、果糖胺和1，5-AG与流行性和偶发性白蛋白尿的相关性; 3）评价GA、果糖胺和1，5-AG与糖尿病和白蛋白尿相关性的种族差异。为了实现这些目标，本研究建议使用来自年轻成人冠状动脉风险发展（CARDIA）研究的储存标本测量GA、果糖胺和1，5- AG，并建立在该前瞻性队列研究的现有基础设施上，该研究广泛收集了社会人口统计学、生活方式和临床变量。这项研究的结果可用于改善风险分层，并为预防糖尿病和微血管并发症的新治疗靶点的开发提供信息。该研究项目也将有助于帮助候选人获得血糖标志物和代谢组学与糖尿病并发症之间关系的专业知识，以建立研究独立性。为了促进候选人的研究培训和职业发展，提出了以下方面的具体培训活动：1）糖尿病和肾脏病理生理学; 2）风险预测的高级统计方法; 3）代谢组学;以及4）研究招募，数据收集和研究管理，这将有助于候选人过渡到独立研究者。总而言之，该指导研究科学家发展奖将通过提供获得血糖标志物和代谢组学及其对糖尿病和白蛋白尿风险影响的专业知识的机会，促进候选人作为独立科学家的专业发展。

DESCRIPTION (provided by applicant): Diabetes is a chronic disease associated with an increased risk of microvascular complications. In the United States, 13% of adults have diabetes and an additional 30% of adults are at high risk of developing diabetes. Nontraditional glycemic markers glycated albumin (GA), fructosamine, and 1,5-anhydroglucitol (1,5-AG)) may provide additional prognostic information to identify individuals at high risk of developing diabetes and microvascular complications. GA, fructosamine, and 1,5-AG reflect short-term hyperglycemia and have been shown to exhibit physiologic effects, including the initiation of signaling pathways, that are active in the development of diabetes microvascular complications. Moreover, important racial differences in GA, fructosamine, and 1,5-AG levels have been reported with African-Americans having higher GA and fructosamine and lower 1,5-AG levels than whites among individuals with and without diabetes. The aims of this research project are: 1) to evaluate the association of GA, fructosamine, and 1,5-AG with incident diabetes; 2) to evaluate the association of GA, fructosamine, and 1,5-AG with prevalent and incident albuminuria; and 3) to evaluate racial differences in the association of GA, fructosamine, and 1,5-AG with diabetes and albuminuria. To address these aims, this study proposes to measure GA, fructosamine, and 1,5- AG using stored specimens from the Coronary Artery Risk Development in Young Adults (CARDIA) Study and build upon the existing infrastructure of this prospective cohort study that has an extensive collection of socio- demographic, lifestyle, and clinical variables. The findings from this study may be used to improve risk stratification and inform the development of new therapeutic targets to prevent diabetes and microvascular complications. This research project will also be instrumental in helping the candidate gain expertise in the relation of glycemic markers and metabolomics with diabetes complications for establishing research independence. To foster the candidate's research training and career development, specific training activities are proposed in: 1) diabetes and renal pathophysiology; 2) advanced statistical methods in risk prediction; 3) metabolomics; and 4) research recruitment, data collection, and study management which will facilitate the candidate's transition to an independent investigator. In summary, this Mentored Research Scientist Development Award will foster the candidate's professional development as an independent scientist by providing an opportunity to gain expertise in glycemic markers and metabolomics and their effects on diabetes and albuminuria risk.